Board Meeting15 Oct 2026, 08:20 pm
Orchid Pharma Board Meeting on Oct 20 to Discuss Fundraising
AI Summary
Orchid Pharma Limited has announced that its Board of Directors will convene on October 20, 2026. The primary agenda item is to consider and evaluate various strategic options for raising capital. These options include issuing equity shares, convertible debentures, or warrants, potentially through qualified institutions placement, preferential issue, private placement, or a public issue of equity and/or debt securities. The company will also explore any other permissible modes of fundraising, subject to necessary regulatory and member approvals.
Key Highlights
- Board meeting scheduled for October 20, 2026.
- To consider and approve fundraising options.
- Potential methods include equity, debentures, and warrants.
- Fundraising may occur via QIP, preferential, or private placement.
- Subject to regulatory and shareholder approvals.
Price Impact
More from ORCHPHARMA